IL232762A0 - Aerosol device for inhalation of drugs that does not depend on the drug profile - Google Patents

Aerosol device for inhalation of drugs that does not depend on the drug profile

Info

Publication number
IL232762A0
IL232762A0 IL232762A IL23276214A IL232762A0 IL 232762 A0 IL232762 A0 IL 232762A0 IL 232762 A IL232762 A IL 232762A IL 23276214 A IL23276214 A IL 23276214A IL 232762 A0 IL232762 A0 IL 232762A0
Authority
IL
Israel
Prior art keywords
drug delivery
aerosolization apparatus
inhalation profile
independent drug
independent
Prior art date
Application number
IL232762A
Other languages
English (en)
Hebrew (he)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL232762A0 publication Critical patent/IL232762A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
IL232762A 2011-12-16 2014-05-22 Aerosol device for inhalation of drugs that does not depend on the drug profile IL232762A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161576768P 2011-12-16 2011-12-16
US201161576735P 2011-12-16 2011-12-16
PCT/US2012/069938 WO2013090841A2 (en) 2011-12-16 2012-12-14 Aerosolization apparatus for inhalation profile-independent drug delivery

Publications (1)

Publication Number Publication Date
IL232762A0 true IL232762A0 (en) 2014-07-31

Family

ID=47501481

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232762A IL232762A0 (en) 2011-12-16 2014-05-22 Aerosol device for inhalation of drugs that does not depend on the drug profile

Country Status (13)

Country Link
US (1) US9744318B2 (enExample)
EP (1) EP2790761B1 (enExample)
JP (1) JP2015500712A (enExample)
KR (1) KR20140103939A (enExample)
CN (1) CN103998087B (enExample)
AU (1) AU2012351947B2 (enExample)
BR (1) BR112014014399A2 (enExample)
CA (1) CA2858247A1 (enExample)
ES (1) ES2924032T3 (enExample)
IL (1) IL232762A0 (enExample)
MX (1) MX2014007277A (enExample)
RU (1) RU2615076C2 (enExample)
WO (1) WO2013090841A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8822663B2 (en) 2010-08-06 2014-09-02 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2622064B1 (en) 2010-10-01 2019-05-29 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US8710200B2 (en) 2011-03-31 2014-04-29 Moderna Therapeutics, Inc. Engineered nucleic acids encoding a modified erythropoietin and their expression
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP3492109B1 (en) 2011-10-03 2020-03-04 ModernaTX, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
HRP20220717T1 (hr) 2011-12-16 2022-07-22 Modernatx, Inc. Modificirani pripravci mrna
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
AR095222A1 (es) * 2013-04-03 2015-09-30 Sanofi Sa Elemento de medición para un dispositivo de inhalación y montaje para un dispositivo de inhalación que comprende un elemento de medición
EP3024523B1 (en) 2013-07-22 2018-08-29 Inhalation Sciences Sweden AB Apparatus and method for generating an aerosol
SG11201602503TA (en) 2013-10-03 2016-04-28 Moderna Therapeutics Inc Polynucleotides encoding low density lipoprotein receptor
JP2017047130A (ja) * 2015-09-04 2017-03-09 原田車両設計株式会社 薬剤吸入装置
KR20180050320A (ko) * 2015-09-09 2018-05-14 노파르티스 아게 분무-건조된 제제의 폐로의 표적화된 전달
CN205916436U (zh) * 2016-07-13 2017-02-01 深圳市合川医疗科技有限公司 一种泡罩穿刺元件
EP3612259B1 (en) * 2017-04-17 2022-11-09 Respira Therapeutics, Inc. Unit dose dry powder inhaler
IL273553B2 (en) * 2017-10-02 2024-09-01 Novartis Ag A method for preparing a pharmacy product
CN108635643B (zh) * 2018-06-04 2025-01-10 润生药业有限公司 一种干粉吸入装置
US11864587B2 (en) * 2018-06-15 2024-01-09 Valley Product Concepts, LLC Capsules for use in personal vaporizers
WO2020135920A1 (en) * 2018-12-28 2020-07-02 Université Libre de Bruxelles Kit for inhaled chemotherapy, and treatment of lung cancer with said kit
EP3947385A1 (en) * 2019-04-04 2022-02-09 Novartis AG Siremadlin succinate
CN110286064B (zh) * 2019-08-05 2021-07-27 贵州大学 一种矿物颗粒润湿性测量装置及其测量方法
CN115089825A (zh) * 2022-07-06 2022-09-23 苏州易合医药有限公司 肺部给药装置

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
CH684746A5 (de) 1993-02-25 1994-12-15 Alusuisse Lonza Services Ag Laminat.
KR100419037B1 (ko) 1994-03-07 2004-06-12 넥타르 테라퓨틱스 폐를통한인슐린의전달방법및그조성물
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
EP0846009B1 (en) * 1994-09-21 2008-03-05 Nektar Therapeutics Apparatus and method for dispersing dry powder medicaments
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
JP3708553B2 (ja) 1995-04-14 2005-10-19 ネクター セラピューティクス 向上した分散性を有する粉末型薬理組成物
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6270869B1 (en) 1998-12-02 2001-08-07 Alusuisse Technology & Management Ltd. Cold formable laminate films
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
DK1666028T3 (da) 1999-10-29 2010-06-21 Novartis Ag Tørre pulversammensætninger med forbedret dispersitet
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
SE0101825D0 (sv) * 2001-05-22 2001-05-22 Astrazeneca Ab An Inhalation device
GB0315509D0 (en) * 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.
GB0427856D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Maniflod for use in medicament dispenser
BRPI0718315A2 (pt) 2006-10-25 2013-11-12 Novartis Ag Aparelho e dispersão de pó, método de fabricação e utilização do aparelho, e componentes que possam ser usados no aparelho e em outros dispositivos.
EP2082764A1 (en) * 2008-01-24 2009-07-29 Boehringer Ingelheim International GmbH Inhaler
CA2724009C (en) * 2008-05-15 2016-10-11 Novartis Ag Pulmonary delivery of a fluoroquinolone
CA3086027C (en) * 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
WO2010039200A2 (en) 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods

Also Published As

Publication number Publication date
AU2012351947A1 (en) 2014-06-26
US9744318B2 (en) 2017-08-29
ES2924032T3 (es) 2022-10-04
CN103998087B (zh) 2017-04-05
WO2013090841A2 (en) 2013-06-20
EP2790761B1 (en) 2022-05-11
CA2858247A1 (en) 2013-06-20
EP2790761A2 (en) 2014-10-22
JP2015500712A (ja) 2015-01-08
RU2014128828A (ru) 2016-02-10
BR112014014399A2 (pt) 2017-06-13
MX2014007277A (es) 2014-07-28
CN103998087A (zh) 2014-08-20
US20140318539A1 (en) 2014-10-30
KR20140103939A (ko) 2014-08-27
WO2013090841A3 (en) 2013-08-08
RU2615076C2 (ru) 2017-04-03
AU2012351947B2 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
IL232762A0 (en) Aerosol device for inhalation of drugs that does not depend on the drug profile
SG10201508662SA (en) Methods for drug delivery
EP2708254A4 (en) CONTAINER FOR NASAL ADMINISTRATION
TWI559916B (en) Medication supplying apparatus
IL232768A0 (en) A drug delivery device
ZA201307378B (en) Medicament delivery device
IL227712A0 (en) Device for sending medicine
PL2600930T3 (pl) Urządzenie wstrzykujące do dostarczania leku
GB201002370D0 (en) Percutaneous drug delivery apparatus
ZA201401269B (en) Intravaginal devices for drug delivery
GB2490770B (en) Drug delivery inhaler devices
SG11201400580VA (en) Pharmaceutical composition for inhalation
PL2665431T3 (pl) Technika dostarczania leków
ZA201306604B (en) Drug delivery device
GB201202091D0 (en) Drug delivery apparatus
ZA201309156B (en) Drug delivery system
IL232946A0 (en) Inhalable medicine containing tiotropium
AU339358S (en) Headgear for positive airway pressure delivery device
LT2793857T (lt) Vaisto įvedimo technologija
AU340344S (en) Atomizing nozzle for nasal therapy
EP2667917A2 (en) Detachable drug delivery device
ZA201308905B (en) Nasal pharmaceutical formulation comprising fluticasone
GB201110632D0 (en) Drug delivery formulations
GB201107477D0 (en) Nasal delivery
GB201104451D0 (en) Nasal delivery